Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,499 | 41,961 | 42,925 | 46,529 | 53,572 |
| Receivables | 29,765 | 26,620 | 39,290 | 22,592 | 19,572 |
| Inventories | 23,872 | 25,532 | 15,691 | 18,442 | 20,905 |
| TOTAL | $112,097 | $112,944 | $118,149 | $109,602 | $118,447 |
| Non-Current Assets | |||||
| PPE Net | 2,895 | 3,265 | 3,629 | 4,023 | 4,419 |
| Intangibles | 77,065 | 86,076 | 95,086 | 104,097 | 113,107 |
| Other Non-Current Assets | 28,139 | 23,192 | 24,839 | 17,276 | 17,739 |
| TOTAL | $108,099 | $112,533 | $123,554 | $125,396 | $135,265 |
| Total Assets | $220,196 | $225,477 | $241,703 | $234,998 | $253,712 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 17,500 | 8,000 | 24,000 |
| Accounts payable and accrued liabilities | 10,107 | 11,882 | 14,635 | 9,038 | 11,776 |
| Accrued Expenses | 53,897 | 53,910 | 67,735 | 62,664 | 56,408 |
| TOTAL | $107,300 | $66,487 | $99,870 | $79,702 | $92,184 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,031 | 30,145 | 17,183 | 34,613 | 18,486 |
| Deferred Revenues | 43,296 | 695 | N/A | 0 | 0 |
| Other Non-Current Liabilities | 102,320 | 112,807 | 111,938 | 116,809 | 126,553 |
| TOTAL | $146,650 | $186,248 | $172,417 | $194,718 | $188,335 |
| Total Liabilities | $253,950 | $252,735 | $272,287 | $274,420 | $280,519 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 210,288 | 209,596 | 209,372 | 188,389 | 188,314 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -1,635,517 | -1,626,935 | -1,608,950 | -1,609,564 | -1,595,075 |
| Other shareholders' equity | 6 | 6 | 6 | 6 | 6 |
| TOTAL | $-33,754 | $-27,258 | $-30,584 | $-39,422 | $-26,807 |
| Total Liabilities And Equity | $220,196 | $225,477 | $241,703 | $234,998 | $253,712 |